Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
Personal hygiene
Source of Contamination and control
GMP Requirement /Guideline
Procedures & Records
Protective Clothing & gowning
Health Examination
Hand wash – How and when
Training & Practice
by Dr. A. Amsavel
The document provides an overview of aseptic practices and microbiology basics. It discusses:
- Definitions of aseptic, sterile, and related terms.
- A brief history of aseptic techniques and milestones like the development of the microscope, iodine, and HEPA filters.
- The importance of microbiology in contamination control and why microbes are studied. It describes common types of microbes like bacteria, fungi, and viruses.
- Sources of contamination and methods for contamination control including cleaning/disinfection, hygiene practices, facilities design with HEPA filters and air flow, and the four pillars of aseptic techniques.
- Personal responsibility in contamination prevention through practices like hand
Contamination control and sterile manufacturingGeorge Wild
Microorganisms like bacteria, viruses, and fungal spores pose a contamination risk in sterile manufacturing. Cleanrooms with strict particle and airflow controls are needed. Personnel procedures aim to minimize shedding of microbes. Sterilization methods like heat aim to achieve a sterility assurance level of 1 in 1 million by killing all microbes or reducing their number below acceptable levels. Key factors in sterilization include the bioburden level and resistance of the most durable microorganism strain present.
The document discusses contamination and personal hygiene in the pharmaceutical industry. It identifies several potential sources of contamination including personnel, buildings and facilities, equipment, materials, manufacturing processes, and HVAC systems. Poor hygiene practices by personnel such as lack of training and cleanliness can lead to microbiological contamination. Maintaining good hygiene practices such as hand washing, using dedicated protective clothing and hair coverings, and restricting street shoes in manufacturing areas are important to prevent contamination and ensure product quality. Regular health checks and hygiene training of personnel are also recommended.
This document discusses guidelines for cleaning and decontamination in a healthcare setting. It covers factors that impact the cleaning process like facility design, environmental controls, and staff safety. It also describes selection and use of cleaning agents like water, detergents, and enzymes. Manual and mechanical cleaning methods are explained including cleaning of different instrument types. Procedures for managing infectious waste and staff training are also outlined.
The document discusses recommendations for the design, construction, and maintenance of facilities for pharmaceutical manufacturing. It covers key areas like location, plant layout, storage, production, and quality control. Specific recommendations are provided for maintaining clean and controlled environments in different areas to minimize risks of contamination and ensure product quality. Personnel hygiene, health monitoring, and environmental monitoring are also important aspects discussed.
This chapter discusses safety in central service departments. It outlines common hazards like sharps, chemicals and fire. Proper personal protective equipment and following safety procedures are emphasized. Special safety precautions are outlined for handling Ethylene Oxide. The importance of reporting accidents and implementing ergonomic practices are discussed. Procedures to prevent patient injuries from equipment or supplies are also reviewed.
This document outlines standards of behavior and practices for cleanrooms and cleanzones. It defines key terms like cleanroom, cleanzone, critical activity, and aseptic processing. The document provides guidelines for behaviors in all cleanrooms and cleanzones, including proper gowning, minimizing contamination, and maintaining orderly work areas. It also outlines additional requirements for aseptic filling suites, such as proper glove sanitization procedures and using aseptic technique. The document states that compliance with these standards will be assessed through microbiological audits and is necessary to meet regulatory expectations for sterile drug production.
Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
Personal hygiene
Source of Contamination and control
GMP Requirement /Guideline
Procedures & Records
Protective Clothing & gowning
Health Examination
Hand wash – How and when
Training & Practice
by Dr. A. Amsavel
The document provides an overview of aseptic practices and microbiology basics. It discusses:
- Definitions of aseptic, sterile, and related terms.
- A brief history of aseptic techniques and milestones like the development of the microscope, iodine, and HEPA filters.
- The importance of microbiology in contamination control and why microbes are studied. It describes common types of microbes like bacteria, fungi, and viruses.
- Sources of contamination and methods for contamination control including cleaning/disinfection, hygiene practices, facilities design with HEPA filters and air flow, and the four pillars of aseptic techniques.
- Personal responsibility in contamination prevention through practices like hand
Contamination control and sterile manufacturingGeorge Wild
Microorganisms like bacteria, viruses, and fungal spores pose a contamination risk in sterile manufacturing. Cleanrooms with strict particle and airflow controls are needed. Personnel procedures aim to minimize shedding of microbes. Sterilization methods like heat aim to achieve a sterility assurance level of 1 in 1 million by killing all microbes or reducing their number below acceptable levels. Key factors in sterilization include the bioburden level and resistance of the most durable microorganism strain present.
The document discusses contamination and personal hygiene in the pharmaceutical industry. It identifies several potential sources of contamination including personnel, buildings and facilities, equipment, materials, manufacturing processes, and HVAC systems. Poor hygiene practices by personnel such as lack of training and cleanliness can lead to microbiological contamination. Maintaining good hygiene practices such as hand washing, using dedicated protective clothing and hair coverings, and restricting street shoes in manufacturing areas are important to prevent contamination and ensure product quality. Regular health checks and hygiene training of personnel are also recommended.
This document discusses guidelines for cleaning and decontamination in a healthcare setting. It covers factors that impact the cleaning process like facility design, environmental controls, and staff safety. It also describes selection and use of cleaning agents like water, detergents, and enzymes. Manual and mechanical cleaning methods are explained including cleaning of different instrument types. Procedures for managing infectious waste and staff training are also outlined.
The document discusses recommendations for the design, construction, and maintenance of facilities for pharmaceutical manufacturing. It covers key areas like location, plant layout, storage, production, and quality control. Specific recommendations are provided for maintaining clean and controlled environments in different areas to minimize risks of contamination and ensure product quality. Personnel hygiene, health monitoring, and environmental monitoring are also important aspects discussed.
This chapter discusses safety in central service departments. It outlines common hazards like sharps, chemicals and fire. Proper personal protective equipment and following safety procedures are emphasized. Special safety precautions are outlined for handling Ethylene Oxide. The importance of reporting accidents and implementing ergonomic practices are discussed. Procedures to prevent patient injuries from equipment or supplies are also reviewed.
This document outlines standards of behavior and practices for cleanrooms and cleanzones. It defines key terms like cleanroom, cleanzone, critical activity, and aseptic processing. The document provides guidelines for behaviors in all cleanrooms and cleanzones, including proper gowning, minimizing contamination, and maintaining orderly work areas. It also outlines additional requirements for aseptic filling suites, such as proper glove sanitization procedures and using aseptic technique. The document states that compliance with these standards will be assessed through microbiological audits and is necessary to meet regulatory expectations for sterile drug production.
This document discusses the transport of contaminated medical equipment from areas of use to the decontamination area. It outlines three main goals of transport: preparing items to avoid damage, transporting without cross-contamination, and ensuring safety. Sources of contaminated items are listed. Methods of transport include dedicated lifts, carts, and hand delivery. User departments should have holding areas marked with biohazard signs. Point-of-use preparation helps prolong equipment life by removing soil before it dries. Guidelines for point-of-use cleaning and transport safety are provided.
The document discusses aseptic filling techniques used to minimize contamination during manufacturing of sterile drug products. It outlines three main areas of control: environmental control through clean rooms and HVAC systems, equipment control using sterilization and sanitization, and individual control with personnel hygiene and gowning. Key aspects covered include clean room classification, HEPA filters, air locks, laminar flow hoods, sterilization methods, and environmental monitoring to ensure an aseptic environment is maintained.
This document discusses microbial contamination control in parenteral manufacturing. It outlines various layers of protection used, including terminal sterilization techniques like autoclaving. It also discusses aseptic processing and sources of contamination control strategies during aseptic manufacture. Other topics covered include blow-fill-seal technology, issues in sterilization by filtration, sterile prefilled syringes, process validation, hazard analysis and critical control points. Key sterilization techniques and the selection of appropriate test organisms to validate these processes are also summarized.
This document provides an overview of cleaning, disinfection and sterilization processes used in healthcare settings. It describes the basic principles and key differences between cleaning, disinfection and sterilization. It outlines the Spaulding classification system for categorizing medical equipment as critical, semi-critical or non-critical to determine the appropriate level of processing required. Examples are provided for each category. Monitoring and documentation of cleaning and sterilization processes are also discussed.
This document provides an overview of sterile packaging and storage. It discusses the objectives of sterile packaging including protecting contents, maintaining sterility, and allowing for aseptic opening. It reviews various reusable and disposable packaging materials like muslin, pouches, and rigid containers. Proper packaging procedures are outlined including preparation, closure methods, labeling, and storage standards. Maintaining sterility through careful handling and following event-related concepts is emphasized.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
This document discusses cleaning and decontamination procedures for medical devices. It covers the importance of cleaning as the first step in reprocessing, factors that impact the cleaning process like environmental design and staff training, and selection and use of cleaning agents. It also explains manual and mechanical cleaning methods and procedures for cleaning different types of instruments.
This document discusses sterile manufacturing and the invisible issues related to particulate matter in sterile injectable pharmaceutical products. It focuses on the risks of viable and non-viable particles, identifying sources of particulate contamination, and strategies for dynamic contamination control. Proper facility design, material and personnel flow, environmental monitoring and validation are needed for aseptic manufacturing to minimize particulate matter that can cause health risks like infection, embolism or allergic reaction when injected.
Sanitization & Hygiene in PharmaceuticalIqra Shafeeq
This document discusses sanitation and hygiene in the pharmaceutical industry. It outlines the importance of high sanitation standards across all aspects of manufacturing, including personnel, premises, equipment, materials and products. Specific hygiene practices for personnel are described, such as health examinations, illness reporting, protective clothing, and restrictions on eating or smoking in production areas. Design of premises and avoidance of cross-contamination through measures like segregated areas, ventilation, airlocks, clothing standards and cleaning validation are also covered. Production operation sanitation procedures including cleaning validation, water systems cleaning and maintenance activities are summarized.
Flash sterilization is a last resort sterilization method used when there is insufficient time to sterilize an item through standard methods. It is not recommended for implantable devices due to risk of infection, but may be unavoidable in some cases. Proper recordkeeping is essential when flash sterilizing implantable devices.
Various low-temperature sterilization technologies have been explored as alternatives to ethylene oxide (EO) due to environmental regulations and health concerns. Acceptable alternative technologies include 100% EO, EO with different stabilizing gases, hydrogen peroxide gas plasma, and peracetic acid. No technology is ideal for all devices and understanding limitations is important for proper application.
EO
The document discusses the requirements and layout for producing sterile parenterals. It describes the different sections needed - cleanup, compounding, aseptic, quarantine, and packing/labeling. Specific requirements for the aseptic area are outlined, including environmental controls like particle counting, slit to agar sampling, and Rodac plates to evaluate air quality. Floors, walls, and benches must be smooth, impervious, and easy to clean. Proper ventilation and filtration of air is essential to maintain sterility. Sources of contamination and prevention methods are also covered.
Contamination control in pharmaceutical industryclientscomp
Contamination control is important in the pharmaceutical industry to ensure safety and efficacy. Contaminants can make medicines toxic or transmit pathogens. Strict sterilization and containment methods are used, including laminar airflow hoods, sealed hatches, and disposable systems. Decontamination is the first step, using autoclaving, dry heat, or hydrogen peroxide vapor sterilization. Cleanrooms provide isolated ventilation to limit contamination of chemicals, biologicals, and pharmaceutical products from the environment.
This document discusses cross-contamination, mix-ups, and clean room practices. It defines key terms like contamination, cross-contamination, and mix-ups. It identifies sources of contamination like personnel, equipment, airflow, and discusses prevention methods like facility design, cleaning validation, and cleanroom classification systems. Personnel clothing, hygiene, and cleaning practices are important to prevent contamination from people. Proper airflow and HVAC systems also help control contamination. Regular monitoring and maintenance of cleanrooms is necessary to ensure quality manufacturing of pharmaceutical products.
The document discusses the history of hygiene practices in hospitals and their role in reducing infection rates. It outlines various sterilization methods used such as autoclaving and highlights the importance of monitoring effective sterilization. The document also discusses the factors that influence infection rates and the methods used for air surveillance in operating theaters, including settle plate counts and slit sampler tests.
The sterilization of surgical instruments is a process that removes all microorganisms from medical instruments before a surgery can take place. Proper sterilization ensures that all equipment has been thoroughly cleaned, sanitized and sterilized, and minimizes the risk of preventable surgical site infections. This process should be completed by a certified central sterilization technician.
The document outlines sanitation and hygiene procedures for personnel in manufacturing facilities. It discusses requirements for health examinations and illness reporting. Operators should be trained on proper hygiene practices like handwashing and avoiding direct contact with products if possible. Facilities should provide proper changing areas, laundry procedures, and separation of eating/drinking/smoking from production. Toilets also cannot open directly into production or storage areas.
This document discusses principles for reducing infections in operation theatres. It covers the history of hygiene practices dating back to biblical texts and emphasizes the importance of hand washing to reduce infections as was demonstrated by Semmelweis. Maintaining sterile environments and following protocols for surgeries can significantly reduce postoperative complications. Regular cleaning and disinfection of operating rooms is important but should be done judiciously without overusing chemicals. Newer non-toxic sterilizing agents are gaining prominence but cost remains a challenge for developing countries. Strict adherence to infection control programs and protocols is key to ensuring biosafety in operating theatres.
This document provides guidance on ensuring sterility in the manufacture of sterile pharmaceutical products through aseptic processing. It discusses quality systems, personnel requirements, facility design, environmental monitoring, equipment qualification, sterilization processes, and other key aspects of aseptic manufacturing. The guidance is intended to advise sterile product manufacturers and regulators on assuring sterility in compliance with regulations.
Cross contamination in Pharmaceuticals - by Jitendra J Jagtapjitendrajagtap1986
The document discusses cross contamination in pharmaceutical manufacturing. It states that the manufacturing environment is critical for product quality and can impact light, temperature, humidity, air movement and microbial and particulate contamination. Poorly designed or maintained air handling systems, inadequate cleaning procedures, and insufficient personnel and equipment procedures can lead to cross contamination originating from the environment, operators or equipment. Cross contamination can be minimized through skilled personnel, adequate facility design, closed production systems, validated cleaning procedures, and appropriate air pressure differentials in heating, ventilation and air conditioning systems.
This document outlines good practices for production operations according to manufacturing and marketing authorizations. It discusses that all handling of materials and products should follow written procedures and be recorded. Deviations from procedures should be avoided or documented. Access should be restricted and operations separated to prevent cross-contamination. Production areas and equipment must be cleaned and free of materials not required before processing. Controls and monitoring ensure proper functioning of equipment and detection of contamination.
This document discusses the transport of contaminated medical equipment from areas of use to the decontamination area. It outlines three main goals of transport: preparing items to avoid damage, transporting without cross-contamination, and ensuring safety. Sources of contaminated items are listed. Methods of transport include dedicated lifts, carts, and hand delivery. User departments should have holding areas marked with biohazard signs. Point-of-use preparation helps prolong equipment life by removing soil before it dries. Guidelines for point-of-use cleaning and transport safety are provided.
The document discusses aseptic filling techniques used to minimize contamination during manufacturing of sterile drug products. It outlines three main areas of control: environmental control through clean rooms and HVAC systems, equipment control using sterilization and sanitization, and individual control with personnel hygiene and gowning. Key aspects covered include clean room classification, HEPA filters, air locks, laminar flow hoods, sterilization methods, and environmental monitoring to ensure an aseptic environment is maintained.
This document discusses microbial contamination control in parenteral manufacturing. It outlines various layers of protection used, including terminal sterilization techniques like autoclaving. It also discusses aseptic processing and sources of contamination control strategies during aseptic manufacture. Other topics covered include blow-fill-seal technology, issues in sterilization by filtration, sterile prefilled syringes, process validation, hazard analysis and critical control points. Key sterilization techniques and the selection of appropriate test organisms to validate these processes are also summarized.
This document provides an overview of cleaning, disinfection and sterilization processes used in healthcare settings. It describes the basic principles and key differences between cleaning, disinfection and sterilization. It outlines the Spaulding classification system for categorizing medical equipment as critical, semi-critical or non-critical to determine the appropriate level of processing required. Examples are provided for each category. Monitoring and documentation of cleaning and sterilization processes are also discussed.
This document provides an overview of sterile packaging and storage. It discusses the objectives of sterile packaging including protecting contents, maintaining sterility, and allowing for aseptic opening. It reviews various reusable and disposable packaging materials like muslin, pouches, and rigid containers. Proper packaging procedures are outlined including preparation, closure methods, labeling, and storage standards. Maintaining sterility through careful handling and following event-related concepts is emphasized.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
This document discusses cleaning and decontamination procedures for medical devices. It covers the importance of cleaning as the first step in reprocessing, factors that impact the cleaning process like environmental design and staff training, and selection and use of cleaning agents. It also explains manual and mechanical cleaning methods and procedures for cleaning different types of instruments.
This document discusses sterile manufacturing and the invisible issues related to particulate matter in sterile injectable pharmaceutical products. It focuses on the risks of viable and non-viable particles, identifying sources of particulate contamination, and strategies for dynamic contamination control. Proper facility design, material and personnel flow, environmental monitoring and validation are needed for aseptic manufacturing to minimize particulate matter that can cause health risks like infection, embolism or allergic reaction when injected.
Sanitization & Hygiene in PharmaceuticalIqra Shafeeq
This document discusses sanitation and hygiene in the pharmaceutical industry. It outlines the importance of high sanitation standards across all aspects of manufacturing, including personnel, premises, equipment, materials and products. Specific hygiene practices for personnel are described, such as health examinations, illness reporting, protective clothing, and restrictions on eating or smoking in production areas. Design of premises and avoidance of cross-contamination through measures like segregated areas, ventilation, airlocks, clothing standards and cleaning validation are also covered. Production operation sanitation procedures including cleaning validation, water systems cleaning and maintenance activities are summarized.
Flash sterilization is a last resort sterilization method used when there is insufficient time to sterilize an item through standard methods. It is not recommended for implantable devices due to risk of infection, but may be unavoidable in some cases. Proper recordkeeping is essential when flash sterilizing implantable devices.
Various low-temperature sterilization technologies have been explored as alternatives to ethylene oxide (EO) due to environmental regulations and health concerns. Acceptable alternative technologies include 100% EO, EO with different stabilizing gases, hydrogen peroxide gas plasma, and peracetic acid. No technology is ideal for all devices and understanding limitations is important for proper application.
EO
The document discusses the requirements and layout for producing sterile parenterals. It describes the different sections needed - cleanup, compounding, aseptic, quarantine, and packing/labeling. Specific requirements for the aseptic area are outlined, including environmental controls like particle counting, slit to agar sampling, and Rodac plates to evaluate air quality. Floors, walls, and benches must be smooth, impervious, and easy to clean. Proper ventilation and filtration of air is essential to maintain sterility. Sources of contamination and prevention methods are also covered.
Contamination control in pharmaceutical industryclientscomp
Contamination control is important in the pharmaceutical industry to ensure safety and efficacy. Contaminants can make medicines toxic or transmit pathogens. Strict sterilization and containment methods are used, including laminar airflow hoods, sealed hatches, and disposable systems. Decontamination is the first step, using autoclaving, dry heat, or hydrogen peroxide vapor sterilization. Cleanrooms provide isolated ventilation to limit contamination of chemicals, biologicals, and pharmaceutical products from the environment.
This document discusses cross-contamination, mix-ups, and clean room practices. It defines key terms like contamination, cross-contamination, and mix-ups. It identifies sources of contamination like personnel, equipment, airflow, and discusses prevention methods like facility design, cleaning validation, and cleanroom classification systems. Personnel clothing, hygiene, and cleaning practices are important to prevent contamination from people. Proper airflow and HVAC systems also help control contamination. Regular monitoring and maintenance of cleanrooms is necessary to ensure quality manufacturing of pharmaceutical products.
The document discusses the history of hygiene practices in hospitals and their role in reducing infection rates. It outlines various sterilization methods used such as autoclaving and highlights the importance of monitoring effective sterilization. The document also discusses the factors that influence infection rates and the methods used for air surveillance in operating theaters, including settle plate counts and slit sampler tests.
The sterilization of surgical instruments is a process that removes all microorganisms from medical instruments before a surgery can take place. Proper sterilization ensures that all equipment has been thoroughly cleaned, sanitized and sterilized, and minimizes the risk of preventable surgical site infections. This process should be completed by a certified central sterilization technician.
The document outlines sanitation and hygiene procedures for personnel in manufacturing facilities. It discusses requirements for health examinations and illness reporting. Operators should be trained on proper hygiene practices like handwashing and avoiding direct contact with products if possible. Facilities should provide proper changing areas, laundry procedures, and separation of eating/drinking/smoking from production. Toilets also cannot open directly into production or storage areas.
This document discusses principles for reducing infections in operation theatres. It covers the history of hygiene practices dating back to biblical texts and emphasizes the importance of hand washing to reduce infections as was demonstrated by Semmelweis. Maintaining sterile environments and following protocols for surgeries can significantly reduce postoperative complications. Regular cleaning and disinfection of operating rooms is important but should be done judiciously without overusing chemicals. Newer non-toxic sterilizing agents are gaining prominence but cost remains a challenge for developing countries. Strict adherence to infection control programs and protocols is key to ensuring biosafety in operating theatres.
This document provides guidance on ensuring sterility in the manufacture of sterile pharmaceutical products through aseptic processing. It discusses quality systems, personnel requirements, facility design, environmental monitoring, equipment qualification, sterilization processes, and other key aspects of aseptic manufacturing. The guidance is intended to advise sterile product manufacturers and regulators on assuring sterility in compliance with regulations.
Cross contamination in Pharmaceuticals - by Jitendra J Jagtapjitendrajagtap1986
The document discusses cross contamination in pharmaceutical manufacturing. It states that the manufacturing environment is critical for product quality and can impact light, temperature, humidity, air movement and microbial and particulate contamination. Poorly designed or maintained air handling systems, inadequate cleaning procedures, and insufficient personnel and equipment procedures can lead to cross contamination originating from the environment, operators or equipment. Cross contamination can be minimized through skilled personnel, adequate facility design, closed production systems, validated cleaning procedures, and appropriate air pressure differentials in heating, ventilation and air conditioning systems.
This document outlines good practices for production operations according to manufacturing and marketing authorizations. It discusses that all handling of materials and products should follow written procedures and be recorded. Deviations from procedures should be avoided or documented. Access should be restricted and operations separated to prevent cross-contamination. Production areas and equipment must be cleaned and free of materials not required before processing. Controls and monitoring ensure proper functioning of equipment and detection of contamination.
This document discusses sanitation and hygiene measures for manufacturing facilities. It outlines ensuring good sanitation practices for premises, personnel, equipment, processes, and materials. Personal hygiene measures include health examinations, training, and illness reporting procedures for employees. The document also describes sanitizing facilities, protecting products from contamination, avoiding cross-contamination, and designing premises to prevent dirt buildup and allow for effective cleaning.
This document provides guidelines for good manufacturing practices for biological products. It outlines the scope, which includes growing microorganisms, extracting substances from tissues, recombinant DNA techniques, hybridoma techniques, and propagating microorganisms in embryos or animals. Biological products covered include allergens, antigens, vaccines, hormones, enzymes, blood and plasma derivatives, immune sera, immunoglobulins, products of fermentation, and diagnostic agents. The principles discuss adhering to good manufacturing practices and controlling biological products through biological techniques. Specific areas covered include personnel, premises and equipment, animal quarters and care, production, labeling, records, quality assurance and control.
The document provides an overview of aseptic processing and contamination control. It defines aseptic processing and compares it to terminal sterilization. Sources of contamination during aseptic processing are discussed, including personnel, air, and equipment. Methods to control contamination are outlined, including quality risk management, contamination control strategies, cleaning and disinfection procedures, environmental monitoring programs, media fills, and quality control testing.
This document discusses good manufacturing practices related to sanitation, prevention of cross-contamination and mix-ups, and processing of intermediates. It emphasizes that premises must be designed and maintained for good sanitation. Strict procedures and controls are needed to prevent cross-contamination between products during production through measures like segregation, air handling, cleaning, and labeling. Intermediates must also be stored and handled carefully according to specifications. Thorough cleaning and changeover procedures are required when switching between products to avoid mix-ups.
Hygiene and sanitation are important for pharmaceutical manufacturing. Personnel must practice good hygiene including health checks, protective clothing, and handwashing. Facilities must be designed to prevent cross-contamination through layout, airflow, and cleaning validations. Waste must be disposed of properly. Strict hygiene protocols are necessary to maintain quality throughout the manufacturing process.
This document outlines personnel hygiene and gowning/de-gowning procedures for pharmaceutical manufacturing. It discusses the importance of sanitation, hygiene, and avoiding cross-contamination. Key points include health examinations and training for personnel, protective clothing and hair coverings, separate changing areas, and procedures for safely donning and doffing gowns to prevent contamination. The goal is to maintain sanitary conditions and protect both personnel and products.
The document discusses basic principles of sanitation and hygiene for good manufacturing practices (GMP). It outlines that high sanitation and hygiene must be practiced in all aspects of manufacturing, including personnel, premises, equipment, materials, and products. Personal hygiene measures include health examinations, training, illness reporting, and avoiding direct contact with products. Sanitary facilities and proper clothing are required. Premises must be designed to prevent dirt buildup and allow for effective cleaning. Cross-contamination is avoided through proper airflow, ventilation, and airlocks. Operations involve sanitizing water systems and conducting maintenance to avoid risks to products.
Design and Construction of plant as per the GMP Guidelines.pdfMohiniTawade
GMP is that part of Quality assurance which ensures that the products are consistently
manufactured and controlled to the Quality standards appropriate to their intended use
Sterile preparation techniques involve maintaining cleanliness levels from grades A through F to minimize contamination. Grade A areas have the highest level of protection for aseptic processing. Various sources of possible contamination like premises, air, personnel and materials are controlled. Personnel follow hygiene procedures and wear protective clothing appropriate for the cleanliness grade. Sampling locations are chosen based on factors like criticality and proximity to products to monitor environmental quality.
This document outlines Good Manufacturing Practices (GMP) for the production of phytomedicines according to Ayurveda, Siddha, and Unani systems of medicine in India. It discusses requirements for facilities, equipment, personnel, documentation, raw materials storage, and quality control. The key points are:
- Facilities must be designed and maintained to allow hygienic production and prevent contamination. Equipment must be suitable for operations and cleaned regularly.
- Personnel involved in production and quality control must be qualified and receive training. Sanitary practices like health checks and protective clothing are required.
- Comprehensive documentation includes specifications, manufacturing processes, training records, and methods to investigate defective
The document discusses sanitation and hygiene principles for good manufacturing practices. It covers ensuring good sanitation for premises, personnel, equipment, processes, materials and containers. It also discusses measures to ensure good personal hygiene. Some key points include having health examinations for personnel and training them on hygiene practices. Facilities should be designed to prevent dirt buildup and allow for effective cleaning. Cross-contamination should be avoided through measures like segregated areas, ventilation systems, protective clothing, and validated cleaning procedures. Production operations must also follow sanitation procedures and keep detailed records.
The document discusses good manufacturing practices (GMP) for neutraceuticals. It outlines the general requirements for premises where neutraceuticals are manufactured, including ensuring premises are designed for easy cleaning and maintenance. Facilities must be provided for ventilation, lighting, water supply and drainage. Equipment must be designed to prevent contamination and ensure products are consistently produced according to quality standards. Personnel hygiene facilities like hand wash basins must also be provided and kept clean. The document provides details on cleaning procedures, waste disposal, pest control, and water supply requirements to ensure neutraceuticals are manufactured under hygienic conditions.
Dr. Prince is an experienced Microbiology teacher with 24 years of experience in teaching various medical and paramedical students.
This ppt explains the types of hospital acquired infection and their control methods.
The document provides guidance on managing a COVID-19 positive patient who requires emergency dental extraction, noting that non-surgical extractions do not generate aerosols so can be performed using proper precautions. It outlines recommended personal protective equipment, infection control procedures, sterilization of dental equipment, environmental cleaning, and dental unit water quality standards to minimize risk of virus transmission when treating patients during the pandemic.
GMP, Goods manufacturer Practices, Drug and Cosmetic actDrSampuranSuahg
GMP (good manufacturing practices) regulations ensure that pharmaceutical products are consistently manufactured and controlled according to quality standards. Key aspects of GMP include maintaining high standards for facilities, equipment, production processes, packaging and labeling, quality control testing, record keeping, and personnel qualifications. GMP helps to minimize risks of contamination and ensures that products meet specifications for identity, strength, quality, purity and safety.
This document provides an overview of current good manufacturing practice (cGMP) guidelines for active pharmaceutical ingredients (APIs) according to the US Food and Drug Administration (FDA). It discusses cGMP requirements for personnel responsibilities and training, facility design and maintenance, process utilities, containment practices, documentation and record keeping, and control of contamination during API manufacturing. The document is intended to provide guidance on complying with cGMP standards to ensure the quality of APIs.
2.5 ENVIRONMENTAL INFECTION RISKS AND PREVENTION STRATEGIES.pptRehmat18
This document discusses environmental infection risks and prevention strategies in healthcare facilities. It covers principles of facility design including traffic flow, ventilation, and separating clean and dirty areas. It also discusses cleaning and disinfection of surfaces and equipment, with a focus on high-touch areas. Proper handling and laundering of reusable textiles is emphasized to prevent transmission of infections.
Similar to Incepta In-plant Training Presentation (20)
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
3. Introduction
Definition:
Contamination can be defined as the introduction or presence of
unwanted impurities/ materials such as dust and particles during the
manufacturing and transportation time or during storage.
Cross contamination can be defined as the introduction of the
starting/raw material, intermediate product or finished product with
another starting material, intermediate product or finished
product.(WHO)
4.
5.
6. Types of Contamination
The most common types of contaminants
include
a) Physical contamination. Examples:
fiber material, particles, chips from
your pill press tooling.
b) Chemical contamination. Examples:
vapor, gasses, moisture, molecules.
c) Biological contamination. Examples:
fungus, bacteria, virus
7. Contaminants can gain entry into a production process stream from
several sources such as:-
• Personnel,
• Poor facility design,
• Incoming ventilation air,
• Machinery and other equipment for production,
• Raw material and semi-finished material,
• Packaging material, Utilities,
• Different media used in the production process as well as for cleaning
and Cleanroom clothing.
10. Premises and Design of Building
Good design of facilities &services equipped with maximum protection
eliminates risk of the entry contaminants into the manufacturing area.
Entry of unauthorized person should be prevented in production, packing
and quality control areas and logical material flow must be developed.
Interior surfaces of walls, floor and ceiling should be smooth, free from
cracks and open joints, should not shed paint particulate matter and should
permit easy and effective cleaning.
Ventilation and light points should be designed to avoid creation of
recesses which are difficult to clean.
11. Should have smooth surfaces free from pitting.
Contact surfaces should be inert, should not be additive or absorptive.
Use dedicated equipments which are easy to clean.
Equipment cleaning aids like bristles, brushes, shedding clothes, that may
raise dust or generate contamination should not be used.
Ensure that all materials of previous product manufactured are removed
and after cleaning there should be no residual cleaning agent left behind.
Repair and maintenance operations should not present any hazard to the
quality of the product. Wrap the cleaned equipment with polythene bags
until use.
12. All personnel prior to and during employment as
appropriate should undergo health examination.
Personnel should wear clean body coverings
appropriate to the duties they perform.
Direct contact should be avoided between the operator’s
hand and starting materials, primary packing materials
and intermediate and finished products.
Appropriate personnel protective equipments (PPE’s)
should be used wherever applicable.
People
13. To reduce air as carrier of
contaminants:
• Control air flow through Air
Handling Unit (AHUs)
• Use of air locks
• Installation of HEPA filters
• Ultra-Low Particulate Air
Air Control
14. •Use appropriate machineries to Loading and unloading
•Dispense one material at a time to prevent
•sampling must be taken in a room that has a suitable air control
system to prevent contamination through airflow
•Regularly check if the cleaning process is effective
•Properly design airflow system to prevent airflow contamination
•Dispensing stations should have proper dust extraction system
•Avoid charging two materials at a time
•Avoid unloading different materials for different batches
simultaneously.
Raw Materials
15.
16. During production
•Dispensing stations for the materials should have proper dust
extraction system and air conditioning system.
•Regularly check equipment for wear and tear to prevent any
compromise to its integrity
•Cleaning must be effectively carried out.
•Do not return used samples to their original containers
•Line clearance must be observed during product changeover
•Ensure proper cleaning of equipment to prevent any biological
contamination